MetaVia Inc

1
NEW
NAS:MTVA (USA)  
$ 1.54 -0.035 (-2.22%) 04:00 PM EST
At Loss
P/B:
1.68
Market Cap:
$ 13.33M
Enterprise V:
$ -2.25M
Volume:
13.33K
Avg Vol (2M):
22.48K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
13.33K
At Loss
Avg Vol (2M):
22.48K

Business Description

Description
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
Name Current Vs Industry Vs History
Cash-To-Debt 117.77
Equity-to-Asset 0.49
Debt-to-Equity 0.02
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.94
Quick Ratio 1.94
Cash Ratio 1.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -326.9
Shareholder Yield % -149.68

Financials (Next Earnings Date:2025-05-09 Est.)

MTVA's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MTVA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

MetaVia Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -4.04
Beta 0.33
3-Year Sharpe Ratio -1.07
3-Year Sortino Ratio -1.28
Volatility % 54.73
14-Day RSI 49.41
14-Day ATR ($) 0.123469
20-Day SMA ($) 1.545892
12-1 Month Momentum % -64.04
52-Week Range ($) 1.29 - 5.3
Shares Outstanding (Mil) 8.65

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

MetaVia Inc Filings

Filing Date Document Date Form
No Filing Data

MetaVia Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

MetaVia Inc Frequently Asked Questions

What is MetaVia Inc(MTVA)'s stock price today?
The current price of MTVA is $1.54. The 52 week high of MTVA is $5.30 and 52 week low is $1.29.
When is next earnings date of MetaVia Inc(MTVA)?
The next earnings date of MetaVia Inc(MTVA) is 2025-05-09 Est..
Does MetaVia Inc(MTVA) pay dividends? If so, how much?
MetaVia Inc(MTVA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1